Abstract:Objective To observe the protein and mRNA expression of LOX-1,eNOS and PPARγ in type 2 diabetic rat aorta,and to investigate the effect of rosiglitazone intervention.Methods Totally 80 Wistar rats (7-week-old male) were randomized into the control group,high fat diet group,diabetic group,and rosiglitazone treatment group (n=20 each).Type 2 diabetes model was developed by intraperitoneal injection with a low dose of streptozotocin,and rats in rosiglization treatment group were treated with rosiglitazone by intragastric administration.After treatment with rosiglitazone for 6 and 12 weeks,animals were sacrificed.Aorta were collected for detecting the protein and mRNA expressions of LOX-1,eNOS and PPARγ,and the differences in expression levels were compared among groups.Results After 6 and 12 weeks,the protein expressions of LOX-1 were up-regulated in diabetic group and rosiglitazone treatment group as compared with control group and high fat diet group (all P＜ 0.01).The protein expression of LOX-1 was down-regulated in rosiglitazone treatment group as compared with diabetic group (P ＜ 0.05).The aorta protein expressions of LOX-1 in high diet group,diabetes group and rosiglitazone treatment group were upregulated after 12 weeks as compared with 6 weeks (all P＜0.01).After 6 and 12 weeks,the aorta protein expressions of eNOS were down-regulated and PPARγ were up-regulated in high fat diet group,diabetic group and rosiglitazone treatment group as compared with control group (all P＜0.01)The aorta protein expression of eNOS was down-regulated and PPARγwas up-regulated in diabetes group as compared with high fat diet group and rosiglitazone treatment group (all P＜0.01).The aorta protein expressions of eNOS in diabetes group and rosiglitazone treatment group were downregulated after 12 weeks as compared with 6 weeks (all P＜0.01).After 6 and 12 weeks,the aorta mRNA expressions of LOX-1 and PPARγ were up-regulated,but the mRNA expressions of eNOS were down-regulated in high fat diet group,diabetes group and rosiglitazone treatment group as compared with control group (all P＜0.05).The aorta mRNA expressions of LOX-1 and PPARγ were up-regulated,but the mRNA expressions of eNOS were down-regulated in diabetes group and rosiglitazone treatment group as compared with high fat diet group (all P＜0.05).The aorta mRNA expressions of LOX-1 and PPARγ were down-regulated,but the mRNA expressions of eNOS were upregulated in rosiglitazone treatment group as compared to diabetic group (all P＜0.01).Conclusions Both hyperglycemia and hyper-lipoproteinemia can induce early coronary atherosclerosis in rats with the abnormal protein and mRNA expressions of LOX-1,eNOS and PPARγ in rat aorta,and the abnormal expressions are more obvious in hyperglycemia combined with hyperlipoproteinemia.Thiazolidinediones can reverse the above abnormal expressions in diabetic rats.

Expression of PPARγin the thoracic aorta of SH R with age and inhibitory effect of rosiglitazone

Expression of P-Pparγ in the Aging Thoracic Aorta of Spontaneously Hypertensive Rat and Inhibitory Effect of Rosiglitazone

Expression of peroxisome proliferator-activated receptor gamma and effect of rosuvastatin on thoracic aorta remodeling in spontaneous hypertensive rats

Effects of Atorvastatin on Myocardium Expression of Peroxisome Proliferator-Activated Receptors in Spontaneously Hypertensive Rats

Effects of Rosiglitazone on Serum Levels of Lipids and Inflammatory Factors in Atherosclerotic Rats

Rosuvastatin-attenuated heart failure in aged spontaneously hypertensive rats via PKCα/β2 signal pathway.

Rosuvastatin Reverses Hypertension-Induced Changes in the Aorta Structure and Endothelium-Dependent Relaxation in Rats Through Suppression of Apoptosis and Inflammation.

Effect of PPARγ Agonist Rosiglitazone on Expression of Matrix Metalloproteinase 2 in Spontaneously Hypertensive Rats

Rosiglitazone ameliorates the dysfunction of endothelial progenitor cells induced by advanced glycation end products

PPAR alpha activator fenofibrate regressed left ventricular hypertrophy and increased myocardium PPAR alpha expression in spontaneously hypertensive rats]

Beneficial and deleterious effects of rosiglitazone on hypertension development in spontaneously hypertensive rats.

The Effect of Rosiglitazone in Modulating Cyclooxygenases-2 in Nonalcoholic Steatohepatitis Rats

[Expression of peroxisome proliferator-activated receptors Y changes with age in vascular smooth muscle cells of spontaneously hypertensive rat].

Effects of rosiglitazone on expressions of peroxisome proliferator-activated receptor gamma and TGF-β1 in rats with adriamycin nephrosis

Protective Effects of Rosiglitazone on Non-Alcoholic Steatohepatitis in Rats

Effects of Rosiglitazone on Hemodynamics and Cardiac Hypertrophy in Rats with Pressure Overload

Rosiglitazone Attenuates Cell Apoptosis Through Antioxidative and Anti-Apoptotic Pathways in the Hippocampi of Spontaneously Hypertensive Rats.

Rosiglitazone Attenuates Myocardial Remodeling in Spontaneously Hypertensive Rats

Expression of oxidized low density lipoprotein receptor-1 in aorta of diabetic rat and intervention of rosiglitazone

The Inhibitory Effects Of Rosiglitazone On Cardiac Hypertrophy Through Modulating The Renin-Angiotensin System In Diet-Induced Hypercholesterolemic Rats

Influence of Rosiglitazone on the Ventricular Haemodynamics,Histological Change,and Apoptosis Level of Cardiomyocytes in Rat's Myocardial Infarction Models